Association of a Missense ALDH2 Single Nucleotide Polymorphism (Glu504Lys) With Benign Prostate Hyperplasia in a Korean Population

키워드

참고문헌 (30)

1. Weng Z, "Subchronic exposure to ethyl tertiary butyl ether resulting in genetic damage in Aldh2 knockout mice", Toxicology, 311, pp.107~114 (2013)
2. Wang Y, "Association of a functional single-nucleotide polymorphism in the ALDH2 gene with essential hypertension depends on drinking behavior in a Chinese Han population", J Hum Hypertens, 27, pp.181~186 (2013)
3. Kato N, "Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians", Nat Genet, 43, pp.531~538 (2011)
4. Hasi T, "Acetaldehyde dehydrogenase 2 SNP rs671 and susceptibility to essential hypertension in Mongolians: a case control study", Genet Mol Res, 10, pp.537~543 (2011)
5. Ishikawa N, "Change of components of the metabolic syndrome in a workers’ health checkup after five years: relation with elevated liver enzymes, gene polymorphisms for ALDH 2, beta3-AR and lifestyle", Nihon Koshu Eisei Zasshi, 52, pp.979~986 (2005)
6. Boyle P, "The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension", Scand J Urol Nephrol Suppl, 168, pp.7~12 (1995)
7. Michel MC, "Association of hypertension with symptoms of benign prostatic hyperplasia", J Urol, 172(4 Pt 1), pp.1390~1393 (2004)
8. Qu X, "Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients", Int Urol Nephrol (2013)
9. Park YW, "The relationship between lower urinary tract symptoms", benign prostatic hyperplasia and the number of components of metabolic syndrome, 2013, pp.82, 674~679
10. Ohta S, "Mitochondrial ALDH2 deficiency as an oxidative stress", Ann N Y Acad Sci, 1011, pp.36~44 (2004)
11. Negri E, "Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia", Int J Cancer, 114, pp.648~652 (2005)
12. Nandeesha H, "Benign prostatic hyperplasia: dietary and metabolic risk factors", Int Urol Nephrol, 40, pp.649~656 (2008)
13. Nikolic ZZ, "Assessment of possible association between rs3787016 and prostate cancer risk in Serbian population", Int J Clin Exp Med, 6, pp.57~66 (2013)
14. Oh JJ, "Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population", Gene, 533, pp.86~93 (2014)
15. Qi J, "Genetic variants in 2q31 and 5p15 are associated with aggressive benign prostatic hyperplasia in a Chinese population", Prostate, 73, pp.1182~1190 (2013)
16. Song J, "Contribution of genetic variation rs266882 to prostate-specific antigen levels in healthy controls with serum PSA below 2.0 ng", ml, 2013, pp.51, 264~274
17. Ullrich PM, "Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia", Urology, 70, pp.487~491 (2007)
18. Yang X, "Common variants at 12q24 are associated with drinking behavior in Han Chinese", Am J Clin Nutr, 97, pp.545~551 (2013)
19. Park BL, "Extended genetic effects of ADH cluster genes on the risk of alcohol dependence: from GWAS to replication", Hum Genet, 132, pp.657~668 (2013)
20. Gao Y, "Genetic variants at 4q21, 4q23 and 12q24 are associated with esophageal squamous cell carcinoma risk in a Chinese population", Hum Genet, 132, pp.649~656 (2013)
21. Gragnoli C, "Overweight condition and waist circumference and a candidate gene within the 12q24 locus", Cardiovasc Diabetol, 12, pp.2~ (2013)
22. Chouery E, "Report on a patient with a 12q24.31 microdeletion inherited from an insulin-dependent diabetes mellitus father", Mol Syndromol, 4, pp.136~142 (2013)
23. Frohnert BI, "Glutathionylated Lipid Aldehydes are Products of Adipocyte Oxidative Stress and Activators of Macrophage Inflammation", Diabetes (2013)
24. Chang BL, "Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer", BJU Int (2013)
25. Xie Z, "Detoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implications", Chem Biol Interact, 202, pp.288~297 (2013)
26. Le Magnen C, "Characterization and clinical relevance of ALDH bright populations in prostate cancer", Clin Cancer Res, 19, pp.5361~5371 (2013)
27. Merendino RA, "Malondialdehyde in benign prostate hypertrophy: a useful marker?", Mediators Inflamm, 12, pp.127~128 (2003)
28. Morita K, "Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus", Cardiovasc Diabetol, 12, pp.132~ (2013)
29. Wang RS, "Effects of aldehyde dehydrogenase-2 genetic polymorphisms on metabolism of structurally different aldehydes in human liver", Drug Metab Dispos, 30, pp.69~73 (2002)
30. Gandaglia G, "The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)", BJU Int, 112, pp.432~441 (2013)

관련 논문AI추천